15-Year heart study tracks patients after balloon treatment
NCT ID NCT06972225
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study reviews the long-term heart health of 1,500 patients who received a drug-eluting balloon to treat coronary artery disease between 2010 and 2025. Researchers will track major heart events like heart attacks, strokes, and repeat procedures. The goal is to better understand the safety and effectiveness of this treatment over many years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
drug-eluting balloon
What this could lead to
If successful, this study could provide valuable long-term safety and effectiveness data for drug-eluting balloons in treating coronary artery disease.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by other factors and may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IUCPQ
RECRUITINGQuébec, Quebec, G1V4G5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact